Immunohistochemistry CD57 Test: Advanced Cancer Biomarker Analysis
Understanding the Immunohistochemistry CD57 Test
The Immunohistochemistry CD57 Test represents a sophisticated diagnostic approach in modern oncology that utilizes specialized staining techniques to detect the presence of CD57 antigens in tissue samples. This powerful diagnostic tool provides crucial insights into cellular composition and immune responses within tumor microenvironments, enabling more accurate cancer classification and personalized treatment strategies.
What Does the CD57 Test Measure?
The Immunohistochemistry CD57 Test specifically detects and quantifies the expression of CD57 antigen, also known as HNK-1 or LEU-7, which serves as a valuable biomarker for several important clinical applications:
- Identification of natural killer (NK) cells and certain T-cell subsets
- Characterization of neuroendocrine tumors and their differentiation patterns
- Distinction between various lymphoma subtypes, particularly peripheral T-cell lymphomas
- Assessment of immune cell infiltration in tumor tissues
- Evaluation of cellular maturation and differentiation states
Who Should Consider the CD57 Test?
This specialized test is particularly beneficial for patients presenting with:
- Suspected lymphoma cases requiring precise classification
- Neuroendocrine tumors needing comprehensive characterization
- Cases with ambiguous histological findings requiring additional biomarker analysis
- Patients undergoing cancer treatment who need immune monitoring
- Individuals with complex hematological malignancies
- Cases requiring differential diagnosis between similar tumor types
Clinical Indications and Symptoms
Patients experiencing unexplained lymphadenopathy, abnormal blood counts, neurological symptoms associated with neuroendocrine tumors, or those with previously diagnosed cancers requiring further characterization may benefit from CD57 testing. The test helps clarify diagnosis when conventional pathology results are inconclusive.
Key Benefits of CD57 Immunohistochemistry Testing
- Enhanced Diagnostic Accuracy: Provides additional molecular evidence to support or refine initial diagnoses
- Personalized Treatment Planning: Helps guide targeted therapy decisions based on specific biomarker expression
- Prognostic Information: CD57 expression patterns can offer insights into disease progression and potential outcomes
- Comprehensive Cancer Profiling: Complements other diagnostic tests for a complete tumor characterization
- Treatment Response Monitoring: Can be used to assess changes in tumor biology during therapy
Understanding Your Test Results
Your CD57 test results will be interpreted by our expert pathologists and typically include:
- Positive Staining: Indicates presence of CD57 antigen, which may suggest specific cell types or tumor characteristics
- Negative Staining: Absence of CD57 expression, which can help rule out certain diagnoses
- Pattern Analysis: The distribution and intensity of staining provide additional diagnostic information
- Clinical Correlation: Results are interpreted in context with your medical history and other test findings
It’s important to discuss your results with your healthcare provider, who can explain their specific implications for your diagnosis and treatment plan. Our pathology team provides comprehensive reports with clear explanations to facilitate informed medical decisions.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry CD57 Test | $76 USD | $112 USD |
Turnaround Time and Sample Requirements
We accept samples daily until 6:00 PM with the following reporting timelines:
- Block Samples: 5 days
- Tissue Biopsy: 5 days
- Large Complex Tissue: 7 days
Sample Type: Submit tumor tissue in 10% formal-saline OR formalin fixed paraffin embedded block. Ship at room temperature. Please provide a copy of the histopathology report, site of biopsy, and clinical history.
Nationwide Testing Availability
GGC DNA provides comprehensive Immunohistochemistry CD57 testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality results regardless of your location.
Take Control of Your Health Today
Don’t leave your diagnosis to chance. The Immunohistochemistry CD57 Test provides the critical information needed for accurate cancer classification and personalized treatment planning. Our experienced team of pathologists and oncology specialists are ready to help you navigate your diagnostic journey with confidence and precision.
Ready to schedule your test? Call us now at +1(267) 388-9828 or book your appointment online. Take the first step toward comprehensive cancer diagnosis and personalized treatment today.
